+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of Detrusor Underactivity on Surgical Outcomes of Laser Prostatectomy: Comparison in Serial 12-Month Follow-Up Outcomes Between Potassium-Titanyl-Phosphate Photoselective Vaporization of the Prostate (PVP) and Holmium Laser Enucleation of the Prostate (HoLEP)



Impact of Detrusor Underactivity on Surgical Outcomes of Laser Prostatectomy: Comparison in Serial 12-Month Follow-Up Outcomes Between Potassium-Titanyl-Phosphate Photoselective Vaporization of the Prostate (PVP) and Holmium Laser Enucleation of the Prostate (HoLEP)



Urology 91: 158-166



To evaluate impacts of preoperative detrusor underactivity (DU) on outcomes of photoselective vaporization of the prostate (PVP) or holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia, and to compare them between the two surgeries. A total of 1423 men, who underwent PVP (group A) or HoLEP (group B), were categorized into four groups: A1 (239 without DU), A2 (432 with DU), B1 (329 without DU), and B2 (423 with DU). DU was defined as bladder contractility index of <100. Outcomes were assessed at 1, 3, 6, and 12 months postoperatively using International Prostate Symptom Score (IPSS), uroflowmetry, and prostate-specific antigen. Successful outcome was defined as reductions by ≥50% of total IPSS at 12 months postoperatively. In all four groups, almost all parameters of IPSS and uroflowmetry improved starting from 1 month. A1 or B1 had greater increases in maximum flow rate than A2 or B2. Decreases of total IPSS in A2 were less than in A1 starting from 1 month after PVP, whereas those in B2 were less than those in B1 as late as 12 months after HoLEP. B2 showed greater improvements in maximum flow rate, subtotal voiding symptom score, bladder voiding efficiency, and total IPSS than A2. In all patients, multivariate regression analysis revealed that the absence of DU, presence of bladder outlet obstruction, and higher baseline total IPSS were independent predictors of successful outcome after surgery, but the type of laser surgery (PVP vs HoLEP) was not. Our data suggest that micturition symptoms, maximum flow rate, bladder voiding efficiency, and quality of life improve starting from the early period after PVP or HoLEP, irrespective of DU. However, patients with DU may have less degree of improvement in micturition after PVP or HoLEP than those without DU.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058055496

Download citation: RISBibTeXText

PMID: 26879733

DOI: 10.1016/j.urology.2015.11.052


Related references

Can preopeative detrusor underactivity have an impact on surgical outcomes of laser prostatectomy: Comparison in serial 3-year follow-up outcomes between 120-W lithium triborate photoselective vaporization of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP). European Urology Suppl.s 16(3): E505-E506, 2017

Can preoperative detrusor underactivity influence surgical outcomes of 120 W HPS vaporization of the prostate (PVP) or holmium laser enucleation of the prostate (HoLEP)? A serial 3-year follow-up study. Neurourology and Urodynamics 37(1): 407-416, 2018

Change in storage symptoms following laser prostatectomy: comparison between photoselective vaporization of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP). World Journal of Urology 33(8): 1173-1180, 2015

Long-Term Outcomes of Laser Prostatectomy for Storage Symptoms: Comparison of Serial 5-Year Followup Data between High Performance System Photoselective Vaporization and Holmium Laser Enucleation of the Prostate. Journal of Urology 199(6): 1591-1599, 2018

Comparison of Surgical Outcomes Between Holmium Laser Enucleation and Transurethral Resection of the Prostate in Patients With Detrusor Underactivity. International Neurourology Journal 21(1): 46-52, 2017

The Efficacy and Safety of Photoselective Vaporization of the Prostate with a Potassium-titanyl-phosphate Laser for Symptomatic Benign Prostatic Hyperplasia according to Prostate Size: 2-Year Surgical Outcomes. Korean Journal of Urology 51(5): 330-336, 2010

A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. Bju International 105(7): 964-969, 2010

Photoselective Potassium-Titanyl-Phosphate Laser Vaporization of the Benign Obstructive Prostate: Observations on Long-Term Outcomes. Yearbook of Urology 2006: 122-123, 2006

Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. Journal of Urology 174(4 Pt 1): 1344-1348, 2005

Pd26-05 A Randomized Trial Comparing Greenlight (Xps) Laser Photoselective Vapo-Enucleation Of The Prostate (Pvep) Versus Holmium Laser Enucleation Of The Prostate (Holep) For Treatment Of Benign Prostate Hyperplasia (Bph). The Journal of Urology 191(4): e760-e761, 2014

Laser prostatectomy: holmium laser enucleation and photoselective laser vaporization of the prostate. Reviews in Urology 15(1): 1-10, 2013

120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. Journal of Endourology 24(1): 75-79, 2010

Effect of preoperative detrusor underactivity on long-term surgical outcomes of photovaporization and holmium laser enucleation in men with benign prostatic hyperplasia: a lesson from 5-year serial follow-up data. Bju International 123(5a): E34, 2019

Comparison of vaporization efficiency of the 80W potassium-titanyl-phosphate (KTP) greenlight (TM) laser and the 120W greenlight high performance system (HPS) laser for photoselective vaporization of the prostate. The Journal of Urology 179(4): 626, 2008

Photoselective potassium-titanyl-phosphate (KTP) laser vaporization of the prostate (PVP) vs transurethral resection of the prostate (TURP). Urology 72(3): 718-719, 2008